Addressing overdiagnosis and overtreatment in cancer: a prescription for change - Test2 - elhamkhani - TriplyDB

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

http://www.wikidata.org/entity/Q35067706

about

Gaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of Life Cancer research in need of a scientific revolution: Using 'paradigm shift' as a method of investigation Cancer prevention as part of precision medicine: 'plenty to be done'One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors Pragmatic medicine in solid cancer: a translational alternative to precision medicine Epidemiology of basal cell carcinoma: scholarly review.Population-based screening for cancer: hope and hype.Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.Truth or Spin? Disease Definition in Cancer Screening.Tumor-induced alterations in lymph node lymph drainage identified by contrast-enhanced MRI Screening mammography--early detection or over-diagnosis? Contribution from Australian data.Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data.Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.Tumor biology, clinicopathological characteristics and prognosis of screen detected T1 invasive non-palpable breast cancer in asymptomatic Chinese women (2001-2014).Prostate Cancer Patient Perspectives on the Use of Information in Treatment Decision-Making: A Systematic Review and Qualitative Meta-synthesis Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials.Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.Precision prevention of oesophageal adenocarcinoma.Overdiagnosis: epidemiologic concepts and estimation.Benefits and harms of mammography screening.Through a glass darkly: the mammography debate.Framing overdiagnosis in breast screening: a qualitative study with Australian experts Future-proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma.Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.Imaging-based screening: maximizing benefits and minimizing harms.The hallmarks of premalignant conditions: a molecular basis for cancer prevention Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.Should Gleason 6 be labeled as cancer?The Treatment of Localized Prostate Cancer in Everyday Practice in Germany Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates Surrogate Markers: Lessons from the Next Gen?A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score Protocol for Biomarker Ratio Imaging Microscopy with Specific Application to Ductal Carcinoma In situ of the Breast.What affects response rates in primary healthcare-based programmes? An analysis of individual and unit-related factors associated with increased odds of non-response based on HCV screening in the general population in Poland.Health technology assessment in evolution - focal therapy in localised prostate cancer.

P2860

Q26751574-D6D8EA78-73E1-44D2-B6DA-1690D932D672 Q26786406-810A0C58-D13E-47F9-ADE3-A9913EE13918 Q26995183-79F8E57F-AB47-41F6-AE6A-06D7D4A2DD70 Q28070143-D0FD2099-8812-452B-86E7-5661A6FB4743 Q28274899-42E316CD-04EA-48FE-8173-6F5588ABA556 Q28391863-FAD7C302-2E80-4FEC-BFBB-BBC012CD3259 Q30235834-2F6ED089-2191-46DD-8874-CC07FDA51771 Q30251601-93DE9306-7983-4B01-9C2D-618B7BDDC049 Q30252065-2FF206BE-D72F-44E0-A98C-07ED43AE2B61 Q30401159-14192699-1D39-469A-9CBC-99FCA0001087 Q30842259-19149020-EA7B-4C17-BE8D-BBC1BE4237B3 Q30851278-0BBE2FC3-57FD-45BE-A47A-B13E79DD2FA9 Q30988479-52977939-240C-4040-976B-6EAA9694EAA2 Q33600507-BBD3CCBF-8130-4B78-885F-6E62C0A0FD78 Q33688599-EE66649D-ECDE-4B42-84C6-8CD8B5944519 Q33746417-3E9B9810-CCC6-4BE2-AB30-79DB804E4E9E Q34142531-C4BD0B50-C054-429C-9A1E-C7EB8A48E520 Q34464782-84CE3111-4818-48B3-9D1C-A3C1C225A6D1 Q35243217-C5C1AEBC-4ED6-4400-BEF6-74FED87C3098 Q35438645-35E635E8-284C-408C-9668-BBE38D8E4717 Q35555984-6E383DBF-A3F3-484F-9849-AD0EA3AC4496 Q35714460-4EB1F243-16AC-4A16-A3C1-E7E896F24703 Q35757874-0EF4F800-6737-4529-8059-EBC3DEC0375B Q35762861-903787E2-7155-4DFD-875A-2DA3EB8BFD09 Q36015250-60806E2E-C927-41D9-AF1B-4C0EE27D4099 Q36029469-B7A9DE1E-D8F4-43C9-869C-4FA3DD2DAD41 Q36258712-037BB679-01AE-4353-8ACC-0F324CB4DF4D Q36278832-B53AE481-648F-47E9-A8EC-2D0C847DA639 Q36366314-6DDEFC44-C98C-49B4-B328-9C1651512C58 Q36679858-16995BDC-70D2-42BF-BE8F-9220E88E4F0A Q36915217-5694DEE8-FCCC-4ACB-A24B-25EC5DFD3428 Q36931932-B0D9B590-653A-4DDA-9A8B-FC921851E8BA Q36996753-F8F7C09B-8BF1-4E27-9BBD-1B9E470830D5 Q37029385-2915FB2A-7D63-4319-9226-415A70EC9F24 Q37044570-E90BD412-107B-4087-A84B-9A531331CF12 Q37059872-2219F6A6-3033-4869-8E8C-E886ED097267 Q37213040-43CEE389-E649-48D1-815F-C32541E7470C Q37389535-96EF3288-A08A-4465-AC89-1677B9ACF878 Q37517210-9D70A6E0-22C1-481D-BD98-EF6EECAEB0A1 Q38223247-F7536E14-C55E-4CC9-9F30-5541ADD6FE04

P2860

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

http://www.wikidata.org/entity/Q35067706

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

@ast

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

@en

type

label

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

@ast

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

@en

prefLabel

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

@ast

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

@en

P1433

Q35067706-825ECDC9-28BB-42A4-A6D6-F5968A92FB6B

P1476

Q35067706-248613E1-A70F-45EB-BE7C-39F59D5FCCA2

P2093

Q35067706-30F3CFBE-8E95-4558-A800-1FF9C019CEC7

Q35067706-6F83EA53-F4DC-4682-BAAB-51B9B34F93E0

Q35067706-7462A673-614C-4033-B845-562879DA6911

Q35067706-79ABA9EA-1EDC-4803-9C65-E243DA60D8CB

Q35067706-82B21D0F-E6A3-4A93-9D38-282D2D57E255

Q35067706-A2479576-02AF-4E4C-91A0-CA853AEFD820

Q35067706-A44499F0-654D-4B03-8473-B09566B3A56C

Q35067706-C5371905-FD70-4F6B-88D6-F4F460DD47B1

Q35067706-C7FB2657-6032-4AC1-ACF5-BF5CBB27C49A

Q35067706-CC75E3F1-6347-48BB-A539-1D38DE5561AC

P2860

Q35067706-0193CD75-E70F-4515-8A9B-CDED1375E4BA

Q35067706-03D2F555-3723-4DDA-A2AB-5F6137060F1A

Q35067706-1070F1CD-1826-4298-B325-95C7F661D680

Q35067706-119AD1DB-B06D-475C-95CA-FE0CF457A657

Q35067706-11F50018-FF37-4104-8D29-6814D88AE709

Q35067706-189E9140-EF2C-4AB6-A036-5179965F78D1

Q35067706-1E20F9F9-6126-4AFD-8E0C-D80F9E5DBB7C

Q35067706-21F0D2AD-E0B9-47DD-ABC7-76E3B3B7FAC3

Q35067706-259786DD-C18D-47CC-A5A5-51D03415ABA7

Q35067706-25D98D50-2351-4EA9-8266-D283D070ABED

P304

Q35067706-9ADBC820-1E73-4080-BE03-72B4A4160A72

P31

Q35067706-C8C6E460-99CC-417D-A7E4-BE048B95083D

P356

Q35067706-5F07C691-8648-465F-B947-9DDC9BF8C8C3

P433

Q35067706-F5F402DC-E057-4B19-9D54-C1A3982AC2DB

P478

Q35067706-7D925F94-1FD5-4DE5-858E-A73E601B7328

P50

Q35067706-99796446-FCB4-44C4-A222-24D35B3EBDCE

P577

Q35067706-F4005EFD-13F3-4231-8BD9-D5AF8714A4C3

P698

Q35067706-A1371BA8-7E6A-41A0-8907-BE37080A80DD

P932

Q35067706-8257115E-83BB-41BB-AA63-27457DD20BEC

P356

S1470-2045(13)70598-9

P1433

The Lancet Oncology

P1476

Addressing overdiagnosis and overtreatment in cancer: a prescription for change

@en

P2093

Brian Reid

http://www.w3.org/2001/XMLSchema#string

David F Ransohoff

http://www.w3.org/2001/XMLSchema#string

Donald A Berry

http://www.w3.org/2001/XMLSchema#string

H Gilbert Welch

http://www.w3.org/2001/XMLSchema#string

Howard Parnes

http://www.w3.org/2001/XMLSchema#string

Ian M Thompson

http://www.w3.org/2001/XMLSchema#string

Kenneth W Kinzler

http://www.w3.org/2001/XMLSchema#string

Laura J Esserman

http://www.w3.org/2001/XMLSchema#string

Peter Nelson

http://www.w3.org/2001/XMLSchema#string

Shelley Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

Comprehensive molecular portraits of human breast tumours

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Reduced lung-cancer mortality with low-dose computed tomographic screening

Rethinking screening for breast cancer and prostate cancer

Whole-genome analysis informs breast cancer response to aromatase inhibition

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

Computed tomography screening and lung cancer outcomes

P304

e234-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(13)70598-9

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24807866

http://www.w3.org/2001/XMLSchema#string

P932

4322920

http://www.w3.org/2001/XMLSchema#string